TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...
Akari Therapeutics, Plc, an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...
Small drugmakers seek deadline extension for GMP compliance as December 2025 approaches, emphasizing the need for support and ...
TipRanks on MSN
Akari Therapeutics initiates GMP manufacturing of AKTX-101
Akari Therapeutics (AKTX) announced the initiation of GMP manufacturing activities to support the development of AKTX-101, the Company’s lead ADC ...
Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...
Subject to TSX Venture Exchange (“ TSXV ”) approval, NurExone has engaged Russo Partners LLC, a New York–based strategic communications firm, (“ Russo ”) for an initial consulting project for up to ...
MIAMI--(BUSINESS WIRE)--OrganaBio, LLC, announces initiation of GMP manufacturing operations at its new cell therapy manufacturing facility, launching a new paradigm in contract and development ...
SCG Cell Therapy (SCG) and the Agency for Science, Technology and Research (A*STAR) in Singapore launched joint laboratories to advance the development of induced pluripotent stem cell (iPSC) ...
SAN DIEGO—With plans to advance 10 drugs into the clinic over the next five years for a variety of disorders, Entos Pharmaceuticals didn’t want to depend on contract manufacturers for the drug ...
BOSTON & SEATTLE & COLUMBUS, Ohio--(BUSINESS WIRE)--GentiBio, Inc., an emerging biotherapeutics company developing best-in-class engineered regulatory T cells programmed to treat autoimmune, ...
Notified in December 2023, the revised Schedule M has shifted the focus from “good manufacturing practices” to “good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback